logo
logo

Gbb Lands Usd 15M Pre-Series B Funding Led By Tiger Jade Capital

Sep 14, 2022•almost 3 years ago

Amount Raised

$15 Million

Round Type

series b

Hong KongArtificial IntelligenceScience And EngineeringFinancial ServicesData And AnalyticsSoftware

Description

Great Bay Bio (hereinafter referred to as "GBB") is pleased to announce today the completion of its USD 15M Pre-series B funding led by Tiger Jade Capital (hereinafter referred to as "Tiger Jade"). The funding was oversubscribed and upsized with participation from one of the world's top life science MNCs, AEF Greater Bay Area Fund (managed by Gobi Partners GBA), and Vectr Ventures, as well as existing institutional investors. The Pre-series B round was advised by DL Securities, a boutique investment bank based in Hong Kong. Tiger Jade was seeded by TigerMed, one of the largest CROs of clinical trials in PRC and covers over 300 companies/clients in its ecosystem, all of which may require services from GBB directly or indirectly

Company Information

Company

GBB

Location

Hong Kong

About

Great Bay Bio (GBB), headquartered in Hong Kong, was founded in 2019 with extensive footprint in the Greater Bay Area. Adhering to the corporate vision of "Global Bioprocessing Made Simpler and More Efficient", GBB is committed to applying AI and other cutting-edge technologies to promote bioprocessing innovations, thus solve pain points, such as long timelines, high cost and low success rate, in drug development. GBB takes improving human life, health and value as its long-term goal.

Related People

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech